State Street Corp increased its stake in USANA Health Sciences, Inc. (NYSE:USNA) by 7.4% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 208,993 shares of the company’s stock after acquiring an additional 14,353 shares during the period. State Street Corp owned approximately 0.85% of USANA Health Sciences worth $13,401,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Alps Advisors Inc. boosted its position in shares of USANA Health Sciences by 0.3% in the second quarter. Alps Advisors Inc. now owns 8,349 shares of the company’s stock worth $535,000 after acquiring an additional 22 shares during the last quarter. BNP Paribas Arbitrage SA boosted its position in shares of USANA Health Sciences by 13.1% in the second quarter. BNP Paribas Arbitrage SA now owns 2,111 shares of the company’s stock worth $135,000 after acquiring an additional 245 shares during the last quarter. Legal & General Group Plc boosted its position in shares of USANA Health Sciences by 7.6% in the second quarter. Legal & General Group Plc now owns 4,040 shares of the company’s stock worth $259,000 after acquiring an additional 284 shares during the last quarter. Rothschild Asset Management Inc. boosted its position in shares of USANA Health Sciences by 1.0% in the second quarter. Rothschild Asset Management Inc. now owns 29,112 shares of the company’s stock worth $1,866,000 after acquiring an additional 298 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its position in shares of USANA Health Sciences by 2.1% in the second quarter. JPMorgan Chase & Co. now owns 16,385 shares of the company’s stock worth $1,050,000 after acquiring an additional 341 shares during the last quarter. 45.02% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: “USANA Health Sciences, Inc. (USNA) Shares Bought by State Street Corp” was reported by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another site, it was stolen and reposted in violation of United States & international trademark and copyright legislation. The legal version of this piece of content can be read at https://www.watchlistnews.com/usana-health-sciences-inc-usna-shares-bought-by-state-street-corp/1723983.html.

In other USANA Health Sciences news, major shareholder Global Ltd Gull sold 40,000 shares of USANA Health Sciences stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $58.41, for a total transaction of $2,336,400.00. Following the transaction, the insider now directly owns 12,326,224 shares of the company’s stock, valued at $719,974,743.84. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Daniel A. Macuga sold 5,751 shares of USANA Health Sciences stock in a transaction that occurred on Monday, August 28th. The shares were sold at an average price of $60.00, for a total transaction of $345,060.00. Following the transaction, the insider now directly owns 2,077 shares in the company, valued at $124,620. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 818,587 shares of company stock worth $52,280,659. 53.20% of the stock is currently owned by corporate insiders.

USNA has been the topic of several research analyst reports. BidaskClub raised shares of USANA Health Sciences from a “sell” rating to a “hold” rating in a research report on Thursday, October 26th. Pivotal Research lifted their price target on shares of USANA Health Sciences from $70.00 to $80.00 and gave the company a “buy” rating in a research report on Wednesday, October 25th.

USANA Health Sciences, Inc. (NYSE:USNA) opened at $67.25 on Friday. The firm has a market cap of $1,612.30, a P/E ratio of 17.78 and a beta of 1.07. USANA Health Sciences, Inc. has a 12-month low of $52.55 and a 12-month high of $71.00.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, October 24th. The company reported $1.02 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.11. The firm had revenue of $261.77 million for the quarter, compared to analysts’ expectations of $259.52 million. USANA Health Sciences had a net margin of 8.79% and a return on equity of 26.38%. USANA Health Sciences’s revenue was up 3.0% compared to the same quarter last year. During the same period in the previous year, the company posted $2.40 earnings per share. research analysts predict that USANA Health Sciences, Inc. will post 3.7 EPS for the current fiscal year.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA).

Institutional Ownership by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.